RALLYBIO CORPORATION Shares Outstanding (Cover Page)
RALLYBIO CORPORATION (RLYB) had Shares Outstanding (Cover Page) of 5.31 million shares as of 2026-07-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-30: Entity Common Stock, Shares Outstanding 5.31M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 5.30M shares.
- 2026-03-06: Entity Common Stock, Shares Outstanding 5.29M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 42.24M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 5.31M shares 10-Q · filed 2026-08-06 |
| 2026-05-08 | 5.30M shares 10-Q · filed 2026-05-13 |
| 2026-03-06 | 5.29M shares 10-K · filed 2026-03-16 |
| 2025-10-31 | 42.24M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 41.79M shares 10-Q · filed 2025-08-07 |
| 2025-05-02 | 41.61M shares 10-Q · filed 2025-05-08 |
| 2025-03-07 | 41.61M shares 10-K · filed 2025-03-13 |
| 2024-11-04 | 41.49M shares 10-Q · filed 2024-11-07 |
| 2024-08-05 | 41.49M shares 10-Q · filed 2024-08-08 |
| 2024-05-06 | 41.45M shares 10-Q · filed 2024-05-09 |
| 2024-03-07 | 37.81M shares 10-K · filed 2024-03-12 |
| 2023-11-03 | 37.79M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 37.80M shares 10-Q · filed 2023-08-08 |
| 2023-05-04 | 37.75M shares 10-Q · filed 2023-05-09 |
| 2023-03-01 | 38.08M shares 10-K · filed 2023-03-06 |
| 2022-11-01 | 32.03M shares 10-Q · filed 2022-11-07 |
| 2022-08-01 | 32.13M shares 10-Q · filed 2022-08-08 |
| 2022-05-04 | 32.13M shares 10-Q · filed 2022-05-10 |
| 2022-03-09 | 32.13M shares 10-K · filed 2022-03-15 |
| 2021-11-08 | 32.13M shares 10-Q · filed 2021-11-10 |
| 2021-09-09 | 32.13M shares 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |